A monoclonal antibody that induces neuronal apoptosis binds a metastasis marker

L T Zhong1, A Manzi, E Skowronski

  • 1Interdepartmental Program in Neuroscience, University of California, Los Angeles, CA 90024, USA.

Cancer Research
|August 2, 2001
PubMed

Insights

Researchers identified isoglobotetraosylceramide (IsoGb4) as a key molecule inducing apoptosis in cortical neurons. This finding reveals a novel mechanism for programmed cell death, potentially impacting neurodegenerative disease research.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Immunology

Background:

  • The precise cell surface molecules regulating apoptosis in cortical neurons remain largely unidentified.
  • Understanding these regulators is crucial for deciphering neuronal cell death pathways.

Purpose of the Study:

  • To identify and characterize the cell surface molecule responsible for inducing apoptosis in cultured neocortical neurons.
  • To elucidate the mechanism by which this molecule transduces apoptotic signals.

Main Methods:

  • Generation of a monoclonal antibody that induces neuronal apoptosis.
  • Purification and structural characterization of the target antigen using mass spectrometry and NMR spectroscopy.
  • Functional assays involving purified antigen and Fumonisin B1 treatment.

Main Results:

  • The apoptosis-inducing antigen was identified as isoglobotetraosylceramide (IsoGb4).
  • IsoGb4 functions as a portable molecule that can transduce apoptotic signals.
  • IsoGb4-induced apoptosis involves an increase in intracellular ceramide levels, mediated by the ceramide synthase pathway.

Conclusions:

  • Isoglobotetraosylceramide (IsoGb4) is a novel inducer of apoptosis in cortical neurons.
  • The findings suggest a new pathway for programmed cell death involving IsoGb4 and ceramide metabolism.
  • IsoGb4's role in apoptosis may have implications for understanding and treating neurological disorders.